Profile
Timothy Sullivan worked as a Senior Director-External Research & Development at Pfizer Inc. from 2015 to 2017.
Prior to that, he was the Immunology Director at ChemoCentryx, Inc. from 2010 to 2012, and then worked as the Director-New Frontier Science at Takeda Pharmaceutical Co., Ltd.
from 2012 to 2015.
From 2017 to 2020, he served as the Vice President-Business Development at Arcus Biosciences, Inc. Sullivan received his undergraduate degree from the University of Notre Dame and his doctorate from the University of California, Berkeley.
Former positions of Timothy Sullivan
| Companies | Position | End |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Corporate Officer/Principal | 2020-04-30 |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | 2016-12-31 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 2015-05-31 |
| CHEMOCENTRYX, INC. | Corporate Officer/Principal | 2012-11-30 |
Training of Timothy Sullivan
| University of Notre Dame | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| ARCUS BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
- Stock Market
- Insiders
- Timothy Sullivan
